Puhlmann Markus (CIK 0001965071)

Latest company ownership

Role: Chief Medical Officer
Shares held
150,000
Last filed at
Jun 24, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 24, 2024 Jan 26, 2024 Perspective Therapeutics, Inc. Chief Medical Officer Buy 95.0 +280,000 25.56% $139.9K
Dec 15, 2023 Dec 19, 2023 Perspective Therapeutics, Inc. Chief Medical Officer Buy 95.0 +595,425 119.09% $188.7K